Articles Tagged With:
-
Federal ‘Right to Try’ Proposal Becomes Law
Many states already allow terminally ill patients access to experimental drugs, and high-profile players backed the federal proposal, but there’s doubt among some in the medical community.
-
Acute Pericarditis or Something Else?
Does the ECG included with this article suggest either acute pericarditis or acute infarction? What key piece of information is missing from the history? How would you interpret the tracing?
-
Tolvaptan Tablets (JYNARQUE)
Tolvaptan is indicated to slow kidney function decline in adults at risk of rapidly progressing autosomal dominant polycystic kidney disease.
-
Rapid Screening for Future Risk of Parkinson’s Disease Dementia
The Montreal Parkinson Risk of Dementia Scale provides a simple eight-item screening tool with high predictive value for developing Parkinson’s disease dementia.
-
Combined Treatments with Medications for Hypertension and Hyperlipidemia Dramatically Reduce the Risk of Stroke
In this real-world study, fixed-dose candesartan/hydrochlorothiazide combined with low-dose rosuvastatin reduced first stroke by 44% in patients at intermediate risk of cardiovascular disease and was well tolerated, with minimum dropout of patients.
-
Chiropractic Spinal Manipulation for Migraine
Chiropractic spinal manipulation offers no benefit over placebo for migraineurs.
-
The Pulmonary Embolism Rule-out Criteria in Low-risk Patients
A cluster randomized trial of the pulmonary embolism rule-out criteria (PERC) compared to usual care for patients estimated to be at low risk of pulmonary embolus (PE) in EDs showed that PERC was non-inferior to usual care at identifying patients who would be free of symptomatic PE at three months, resulting in less use of healthcare resources.
-
With Funding Announcement, Trump Begins Reshaping Title X
Funding announcement to reshape Title X.
-
What’s Your Approach to Abnormal Uterine Bleeding?
Statistics indicate that one-third of outpatient gynecologist visits are for abnormal uterine bleeding, with the condition accounting for more than 70% of gynecologic consultations in the perimenopausal and postmenopausal years.
-
Research Examines Self-administered DMPA
New research indicates that use of subcutaneous depot medroxyprogesterone (DMPA-SC, marketed as Sayana Press, Pfizer Inc.) may help women to continue using injectable contraception longer than women who receive traditional intramuscular injections.